✦ LIBER ✦

Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: A review

✍ Scribed by K.T. Park; Dorsey Bass

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 89 KB
Volume: 17
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21488

No coin nor oath required. For personal study only.

✦ Synopsis

The United States spends more for healthcare than any other country in the world. With the rising prevalence of both Crohn's disease and ulcerative colitis, inflammatory bowel disease (IBD) represents the leading chronic gastrointestinal disease with increasing healthcare expenditures in the US. IBD costs have shifted from inpatient to outpatient care since the introduction of biologic therapies as the standard of care. Gastroenterologists need to be aware of the national cost burden of IBD and clinical practices that optimize cost-efficiency. This investigation offers a systematic review of the economics of IBD and evidence-based strategies for cost-effective management.

📜 SIMILAR VOLUMES

Hospitalizations for inflammatory bowel

Hospitalizations for inflammatory bowel disease: Profile of the uninsured in the United States

✍ Geoffrey C. Nguyen; Justina Sam; Sanjay K. Murthy; Gilaad G. Kaplan; Jill M. Tin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## Background: Inflammatory bowel disease (ibd) patients may be at increased risk for having no health insurance. our objectives were to assess the prevalence of hospitalized ibd patients without insurance in the us and to characterize predictive factors. ## Methods: We identified ibd admissions

Health care and cost of medication for i

Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: A multicenter, prospective, internet-based study

✍ I. Blumenstein; H. Bock; C. Weber; A. Rambow; W. Tacke; R. Kihn; R. Pfaff; S. Or 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 1 views

## Background: Studies examining the treatment reality of ibd patients in germany have been limited, as networking among deliverers of care and reliable documentation of medical, demographic, and economic data are lacking. the aim of the present study was to establish an internet-based treatment re

Role of ASCA and the NOD2/CARD15 mutatio

Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: A project of the European Collaborative Study Group on Inflammatory Bowel Disease

✍ Shmuel Odes; Michael Friger; Hillel Vardi; Greet Claessens; Xavier Bossuyt; Lene 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Background: Nod2/card15, the first identified susceptibility gene in crohn's disease (cd), is associated with ileal stenosis and increased frequency of surgery. anti-saccharomyces cerevisiae antibody (asca), a serological marker for cd, is associated with ileal location and a high likelihood for